Infectious disease
RSV Fusion glycoprotein F0 precursor 106-114 (HLA-B57) RARRELPRF
Product number: EP12233_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
The peptide RSV Fusion glycoprotein F0 precursor 106-114 (HLA-B57) with the amino acid sequence RARRELPRF is a linear peptidic epitope (epitope ID 53201) studied as part of Fusion glycoprotein F0 (UniProt:O36634) from Human respiratory syncytial virus.
RSV Fusion glycoprotein F0 precursor 106-114 (HLA-B57) has been studied for immune reactivity in publication and has been tested in T cell assays.
TechData
| Sequence: | RARRELPRF |
| Gene: | F |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 5 mg |
| Counterion: | TFA |
| Protein: | Fusion glycoprotein F0 |
| Species: | Human respiratory syncytial virus (RSV) |
| Allele: | HLA-B*57 |
| Application: | Flow Cytometry |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |